Search Results - "Staats, HF"

Refine Results
  1. 1
  2. 2

    Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection by Abraham, Soman N, McLachlan, James B, Hart, Justin P, Pizzo, Salvatore V, Shelburne, Christopher P, Staats, Herman F, Gunn, Michael D

    Published in Nature immunology (01-12-2003)
    “…Palpable swelling of regional lymph nodes is a common sequela of microbial infections but the mechanism responsible for the sequestration and subsequent…”
    Get full text
    Journal Article
  3. 3

    Mucosal and Systemic Adjuvant Activity of Alphavirus Replicon Particles by Thompson, Joseph M., Whitmore, Alan C., Konopka, Jennifer L., Collier, Martha L., Richmond, Erin M. B., Davis, Nancy L., Staats, Herman F., Johnston, Robert E.

    “…Vaccination represents the most effective control measure in the fight against infectious diseases. Local mucosal immune responses are critical for protection…”
    Get full text
    Journal Article
  4. 4

    Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4 by Marinaro, M, Staats, HF, Hiroi, T, Jackson, RJ, Coste, M, Boyaka, PN, Okahashi, N, Yamamoto, M, Kiyono, H, Bluethmann, H

    Published in The Journal of immunology (1950) (15-11-1995)
    “…Despite pathophysiologic effects including diarrhea, cholera toxin (CT) is a potent mucosal immunogen and adjuvant. We investigated the influence of CT on T…”
    Get full text
    Journal Article
  5. 5

    IL-1 Is an Effective Adjuvant for Mucosal and Systemic Immune Responses When Coadministered with Protein Immunogens by Staats, Herman F, Ennis, Francis A., Jr

    Published in The Journal of immunology (1950) (15-05-1999)
    “…Mucosal immunization with soluble protein Ag alone may induce Ag-specific tolerance, whereas mucosal immunization with Ag in the presence of a mucosal adjuvant…”
    Get full text
    Journal Article
  6. 6

    An In Vitro Model of Mast Cell Desensitization by Hofmann, A.M, Jin, C, Staats, H.F, Abraham, S.N

    Published in Journal of allergy and clinical immunology (01-02-2010)
    “…Murine bone marrow derived MCs were sensitized with anti-TNP IgE…”
    Get full text
    Journal Article
  7. 7

    Use of a Mast Cell Activator as a Mucosal Adjuvant for Pertussis Vaccines by Hofmann, A.M, Staats, H.F, Abraham, S.N

    Published in Journal of allergy and clinical immunology (01-02-2009)
    “…The mast cell activator, C48/80, is a powerful adjuvant for pertussis nasal vaccines capable of evoking strong systemic and nasal immune responses, which is…”
    Get full text
    Journal Article
  8. 8

    Cytokines as Adjuvants for the Induction of Anti-Human Immunodeficiency Virus Peptide Immunoglobulin G (IgG) and IgA Antibodies in Serum and Mucosal Secretions after Nasal Immunization by Bradney, Curtis P, Sempowski, Gregory D, Liao, Hua-Xin, Haynes, Barton F, Staats, Herman F

    Published in Journal of Virology (01-01-2002)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  9. 9

    Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery by Wang, Sheena H, Thompson, Afton L, Hickey, Anthony J, Staats, Herman F

    “…Dry powder vaccine formulations have proved effective for induction of systemic and mucosal immune responses. Here we review the use of dry vaccines for…”
    Get more information
    Journal Article
  10. 10

    Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella by VanCott, JL, Staats, HF, Pascual, DW, Roberts, M, Chatfield, SN, Yamamoto, M, Coste, M, Carter, PB, Kiyono, H, McGhee, JR

    Published in The Journal of immunology (1950) (15-02-1996)
    “…We have assessed regulatory Th cell and cytokine responses in mice after oral immunization with recombinant Salmonella (BRD 847) expressing fragment C of…”
    Get full text
    Journal Article
  11. 11

    Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization by Staats, Herman F, Bradney, Curtis P, Gwinn, William M, Jackson, Shawn S, Sempowski, Gregory D, Liao, Hua-Xin, Letvin, Norman L, Haynes, Barton F

    Published in The Journal of immunology (1950) (01-11-2001)
    “…Cholera toxin (CT) is frequently used as an experimental adjuvant intranasally for the induction of systemic and mucosal immunity. However, CT is highly…”
    Get full text
    Journal Article
  12. 12

    A Novel Neurotoxoid Vaccine Prevents Mucosal Botulism by Kobayashi, Ryoki, Kohda, Tomoko, Kataoka, Kosuke, Ihara, Hideshi, Kozaki, Shunji, Pascual, David W, Staats, Herman F, Kiyono, Hiroshi, McGhee, Jerry R, Fujihashi, Kohtaro

    Published in The Journal of immunology (1950) (15-02-2005)
    “…The threat posed by botulism, classically a food- and waterborne disease with a high morbidity and mortality, has increased exponentially in an age of…”
    Get full text
    Journal Article
  13. 13

    Helper T cell subsets for immunoglobulin A responses : oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues by XU-AMANO, J, KIYONO, H, JACKSON, R. J, STAATS, H. F, FUJIHASHI, K, BURROWS, P. D, ELSON, C. O, PILLAI, S, MCGHEE, J. R

    Published in The Journal of experimental medicine (01-10-1993)
    “…Antigen-specific B cell responses to mucosally delivered proteins are dependent upon CD4-positive T helper (Th) cells, and the frequency of Th1 and Th2 cell…”
    Get full text
    Journal Article
  14. 14

    Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A) by Staats, HF, Nichols, WG, Palker, TJ

    Published in The Journal of immunology (1950) (01-07-1996)
    “…To optimize mucosal immune responses to the HIV-1 peptide vaccine candidate T1SP10 MN(A), we intranasally immunized BALB/c and C57BL/6 mice with C4/V3 HIV-1…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Detection of mucosal antibodies in HIV type 1-infected individuals by Wright, Peter F, Kozlowski, Pamela A, Rybczyk, G Kyle, Goepfert, Paul, Staats, Herman F, VanCott, Thomas C, Trabattoni, Daria, Sannella, Edith, Mestecky, Jiri

    Published in AIDS research and human retroviruses (20-11-2002)
    “…HIV-1-specific mucosal IgA antibodies may correlate with protection in highly exposed but uninfected individuals, but have been detected at highly variable…”
    Get more information
    Journal Article
  19. 19

    Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide- specific CTLs and protection against tumor development in vivo by Porgador, A, Staats, HF, Faiola, B, Gilboa, E, Palker, TJ

    Published in The Journal of immunology (1950) (15-01-1997)
    “…To evaluate the ability of mucosal immunization protocols using peptide immunogens to induce CTL responses, BALB/c and C57BL/6 mice were immunized intranasally…”
    Get full text
    Journal Article
  20. 20

    Mucosal immunity to infection with implications for vaccine development by Staats, H F, Jackson, R J, Marinaro, M, Takahashi, I, Kiyono, H, McGhee, J R

    Published in Current opinion in immunology (01-08-1994)
    “…The induction of effective mucosal immunity that also provides systemic immunity is a considerable challenge. Over the past two years, efforts to develop novel…”
    Get more information
    Journal Article